Australian device pre-market assessment changes: submissions, costs and timelines
This article was originally published in SRA
Australia’s Therapeutic Goods Administration received 21 responses to its consultation on amending pre-market assessment requirements for medical devices.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.